Enanta Pharmaceuticals | Marktkapitalisierung

Market Capitalization Veränderung Datum
AbbVie USD 273.6B 10.51B 2023-12
Acorda Therapeutics USD 16M 2M 2023-06
Amgen USD 154.14B 10.38B 2023-12
Arrowhead Research USD 3.29B 407M 2023-12
AstraZeneca GBP 164.29B 7.78B 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 37.5B 274M 2023-12
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Enanta Pharmaceuticals USD 198M 37M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Halozyme Therapeutics USD 4.88B 157M 2023-12
Heron Therapeutics USD 145M 6M 2023-09
Immunic USD 68M 2M 2023-12
Incyte USD 12.89B 1.18B 2024-03
Insmed USD 3.95B 486M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Ligand Pharmaceuticals USD 1.26B 19M 2024-03
Marinus Pharmaceuticals USD 407M 142M 2023-09
Merck USD 314.33B 38.07B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Novavax USD 684M 43M 2023-09
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Enanta Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.